R. Valks et al., Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs, ARCH DERMAT, 137(1), 2001, pp. 61-65
Background: Graft-vs-host disease (GVHD) is divided into acute and chronic
phases based on time and clinical and histological features. The criterion
of 100 days after transplantation for separating acute GVHD from chronic GV
HD has been challenged on the following points: (1) the lichenoid rash of c
hronic GVHD may be observed as early as day 31 and acute GVHD may persist a
fter day 100 in some cases, and (2) specific histological features do not c
onsistently separate acute from chronic GVHD defined as the number of days
after transplantation. However, the appearance of acute cutaneous GVHD afte
r day 100 is not well established.
Observations: Three patients developed a rash with clinical and histologica
l features of acute GVHD between days 153 and 192 after allogeneic bone mar
row transplantation or peripheral blood stem cell transplantation. III all
patients, the late flare of acute GVHD occurred after tapering or suspendin
g the immunosuppressive regimen with cyclosporine or corticosteroids, and w
as accompanied by stigmata of chronic GVHD in other target organs.
Conclusions: The rash of acute GVHD may be observed as late as 192 days aft
er transplantation, especially after tapering or suspending the immunosuppr
essive drugs, and should be considered in the differential diagnosis of lat
e erythematous eruptions after transplantation.